Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRT

NCT05839002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 187

Last updated 2023-05-03

No results posted yet for this study

Summary

In this case-only study, the investigators try to define a novel staging parameter, the Primary Tumor Burden Score (PTBS).

Conditions

  • Neoplasm, Esophagus
  • Neoplasm, Squamous Cell

Interventions

PROCEDURE

nCRT

ESCC patients that recieved surgery and nCRT.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Fudan University

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-21
Primary Completion
2021-12-01
Completion
2023-03-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05839002 on ClinicalTrials.gov